TFIPS
TEVA icon

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Teva Pharmaceuticals TEVA Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Hold
3,604
– – 0.03% 289
2026
Q1 		$109K Sell
3,604
-725
-17% -$23.3K 0.04% 255
2025
Q4 		$135K Hold
4,329
– – 0.03% 219
2025
Q3 		$87.4K Hold
4,329
– – 0.02% 285
2025
Q2 		$72.6K Sell
4,329
-9,771
-69% -$158K 0.02% 313
2025
Q1 		$217K Hold
14,100
– – 0.07% 128
2024
Q4 		$311K Hold
14,100
– – 0.1% 84
2024
Q3 		$254K Hold
14,100
– – 0.09% 100
2024
Q2 		$229K Hold
14,100
– – 0.09% 99
2024
Q1 		$199K Hold
14,100
– – 0.08% 111
2023
Q4 		$147K Buy
+14,100
New +$132K 0.07% 121
2021
Q3 		$152K Hold
15,600
– – 0.18% 63
2021
Q2 		$154K Hold
15,600
– – 0.18% 66
2021
Q1 		$180K Buy
15,600
+15,000
+2,500% +$172K 0.26% 57
2020
Q4 		$5.79K Buy
+600
New +$5.75K 0.01% 339

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's TEVA Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 3,604 shares worth $122K. The position accounts for 0.03% of the portfolio, ranked #289.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in TEVA in Q4 2020 and has held it in 15 quarters since. The position peaked at $311K in Q4 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 3,604 shares of Teva Pharmaceuticals worth $122K as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.03% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #289 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Teva Pharmaceuticals position peaked at $311K in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.